0ME.F Twist Bioscience Corp

Healthcare Biotechnology Frankfurt Exchange
127.95 EUR
Close of Nov 12, 2026
21.69 183.50
Market cap
EUR 8.48B
P/E
-
P/B
19.37x
ROE
-32.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is 0ME.F undervalued?

Graham number

The Graham number of Twist Bioscience Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Twist Bioscience Corp fundamental analysis

No fundamental analysis for Twist Bioscience Corp yet.

Twist Bioscience Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DN…

Full company profile